Venezuela, 11 de Febrero de 2012

Año 2011, Volumen 61 - Número 3
Año 2011, Volumen 61
Número 3


SLAN - Capítulo Venezolano

SLAN - México

SLAN - Brasil

SLAN - Chile






Desarrollado por:
Estudio Pro
HOME > EDICIONES > Año 2005, Volumen 55 - Número 1

Trabajos de Investigación
Efecto de la suplementación con las vitaminas B12, B6 y ácido fólico en los niveles de homocisteina y lípidos plasmáticos en pacientes con hiperlipoproteinemia secundaria tipo IV

Alba Rosa Morón de Salim y Antonio Garcés Pasamontes
Departamento de Bioquímica. Escuela de Medicina. Facultad de Ciencias de la Salud. Universidad de Carabobo. Valencia. Estado Carabobo. Venezuela

SUMMARY
Effect of the suplementación of vitamins B12, B6 and folic acid on homocysteine and plasmatic lipids in patients with hyperlipoproteinemic secondary type IV

The cases of hyperlipoproteinemic secondary type IV are manifested by elevation of triglycerides, with normal or high cholesterol and lightly high homocysteine. The effect of vitamins B12, B6 and folic acid, on homocysteine and lipids, in 24 male patients, 35-68 years, with hiperlipoproteinemia secondary type IV with myocardial isquemic, and without previous treatment of hipolipemiant, was investigated. The patients were supplemented with therapeutic doses tablets of vitamin B12, 500 (µg/day); B6, (600 mg/day) and folic acid (20 mg/day), during 120 days. Homocysteine, triglycerides, total and fractional cholesterol, at (basal), 30, 60, 90 and 120 days, were determined. Descriptive statistical analyses were applied, coefficient of correlation of Pearson and proves of "t", with a p < 0.005; the data were processed by statistical program SPSS version 8.0. The results showed a decrease in the levels of homocysteine from basal 17,1±0,7 µmol/L to 13,18±0,83 µmol/L, at the end of experimental period. The triglycerides (TG), total cholesterol (TC), low density lipoprotein (LDL), very low density lipoprotein (VLDL) showed a reduction of (21,8 mg/dl; 8,5 mg/dl; 5,87 mg/dl; respectively) for every µmol/L of reduced homocysteine, with (p <0,001) for triglycerides. High density lipoprotein (HDL) increased 1,1 mg/dl and coronary risk descent in 24%. We concluded that therapeutic doses of vitamins B12, B6 and folic acid, may is effective in decreased plasmatic homocysteine levels and lipids, mainly triglycerides, with a reduction of coronary risk, to these type of patients, with not collateral effects of neuropathy

Key words: hiperlipoproteinemia, homocysteine, vitamin B12, vitamin B6, folic acid, triglycerides, coronary risk.



Recibido: 22/12/2004
Aceptado: 20/04/2005



HOME > EDICIONES > Año 2005, Volumen 55 - Número 1 Ir al principio

PRIVACIDAD | ACCESIBILIDAD
ALAN-VE ISSN 0004-0622 - Depósito Legal: pp 199602DF83
Sociedad Latinoamericana de Nutrición
Producción editorial en Venezuela: Capítulo Venezolano - RIF: J-30843129-0
Urbanización Santa María, primera transversal, No. 417-214, Planta Alta
Tele-Fax: (+58-212) 283.8618
E-mail info@alanrevista.org
Código Postal: 1070
Caracas - Venezuela